COMMENTARY
Astellas' Inventorship Issue with Professor Ochiai - What If This Were a US Case?
Paul KingMcIntyre Harbin & Kingpking@mhk-law.comPart II: OwnershipIn the last issue, we discussed Professor Ochiai's inventorship issue raised in the Prograf legal action case in Japan, and how such an issue would be handled in a US lawsuit. In this issue,…
To read the full story
COMMENTARY
- Japan’s Trading Houses Gain Ground in Pharma, Rewriting the Industry Playbook
November 10, 2025
- The Price of Stability: Who Bears Japan’s Drug Distribution Burden?
October 27, 2025
- Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
October 7, 2025
- Inside Eylea - 1: Patent Issues Behind Differences in Biosimilar Indications for AMD and DME
October 6, 2025
- FPMAJ Chair’s Call for Blanket Drug Price Hike: Bold Pitch or Wild Throw?
September 30, 2025
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…





